| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
501 |
446 |
$31K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,030 |
601 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
321 |
231 |
$15K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
121 |
107 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
300 |
264 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
104 |
70 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
186 |
87 |
$2K |
| 87428 |
|
159 |
109 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
26 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
94 |
86 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
13 |
$772.44 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
27 |
$479.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
29 |
25 |
$27.50 |
| 1160F |
|
174 |
161 |
$0.00 |
| 1159F |
|
174 |
161 |
$0.00 |
| 3078F |
|
155 |
142 |
$0.00 |
| 3725F |
|
30 |
28 |
$0.00 |
| 3074F |
|
268 |
246 |
$0.00 |
| 1036F |
|
97 |
81 |
$0.00 |
| 3079F |
|
34 |
30 |
$0.00 |